ISD Immunotech is developing STING modulators to treat severe Systemic lupus erythematosus (SLE) or Lupus by targeting the STING pathway. SLE is a complex and devastating autoimmune disease with few to no good options for treatment especially for the most severe patients. STimulator of INterferon Gene (STING) is a target that controls innate immunity and has shown to be overactive in severe SLE making it an exciting new therapeutic target for SLE.
Company Details
- Founded
- -
- Address
- Copenhagen Bioscience Park, Ole Maaloes Vej 3,denmark
- in****@****ech.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- isd-immunotech.com
- HQ
- Copenhagen, DK
Isd-Immunotech Questions
Isd-Immunotech's website is isd-immunotech.com
Isd-Immunotech's LinkedIn profile is https://dk.linkedin.com/company/isd-immunotech
Isd-Immunotech's industry is
Biotechnology Research
Isd-Immunotech's top competitors are
Sylph,
Biomatics Technology,
Pancryos,
Viking Invest,
Healthtunes.org,
Cobosci - Biomedical Research,
Amino Wool,
Synapsebio,
Galecto, Inc.,
Biorigin.
Isd-Immunotech's support email address is info@isd-immunotech.com
Isd-Immunotech's categories are Biotechnology Research
Isd-Immunotech's founding year is 2013
